ProCE Banner Activity

GeparSixto: Neoadjuvant Chemotherapy ± Carboplatin in Patients With HER2-Positive or Triple-Negative Early Breast Cancer

Slideset Download
Conference Coverage
Adding carboplatin to neoadjuvant chemotherapy significantly improved DFS in triple-negative but not HER2+ early breast cancer.

Released: December 16, 2015

Expiration: December 14, 2016

No longer available for credit.

Share

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Genentech BioOncology

Novartis Pharmaceuticals Corporation